SCHEMBL1015063

SCHEMBL1015063

COC(=O)c1cc(Cl)ccc1NC(=O)C(=O)NCc1cccc(-c2ccco2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.58
SMN1; SMN2 Q16637 4/20 0.49
THRB P10828 1/20 0.49
PRMT6 Q96LA8 1/20 0.46
ALDH1A1 P00352 6/20 0.45
HPGD P15428 5/20 0.45
NPC1 O15118 1/20 0.45
TSHR P16473 5/20 0.44
HSD17B10 Q99714 4/20 0.44
KDM4E B2RXH2 4/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
MAPT P10636 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
POLB P06746 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ESR1 P03372 1/20 0.43
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016073 0.89 SERPINE1 (0.72) SERPINE1SMN1; SMN2THRBPRMT6TSHR
SCHEMBL1015337 0.87 SERPINE1 (0.62) SERPINE1SMN1; SMN2THRBPRMT6ALDH1A1
SCHEMBL1016838 0.85 SERPINE1 (0.81) SERPINE1SMN1; SMN2THRBALDH1A1HPGD
SCHEMBL17530198 0.82 SERPINE1 (0.47) SERPINE1SMN1; SMN2THRBPRMT6ALDH1A1
SCHEMBL1016186 0.81 THRB (0.54) SERPINE1SMN1; SMN2THRBALDH1A1HPGD
SCHEMBL417150 0.79 SERPINE1 (0.60) SERPINE1SMN1; SMN2THRBALDH1A1HPGD
SCHEMBL1015171 0.78 SERPINE1 (0.75) SERPINE1SMN1; SMN2THRBPRMT6TSHR
SCHEMBL1016295 0.77 LCLAT1 (0.49) SERPINE1SMN1; SMN2THRBALDH1A1HPGD
SCHEMBL17530197 0.75 SERPINE1 (0.50) SERPINE1PRMT6ALDH1A1HPGDNPC1
SCHEMBL7040714 0.74 PPARG (0.76) SMN1; SMN2ALDH1A1HPGDNPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885SMN1; SMN2 2290/4885THRB 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.